A care-coordination membership that pairs you with an independent licensed partner provider for personalized consultations, lab review, and lifestyle supplements — all managed from one private online portal. Your membership is designed around comprehensive, personalized care—including provider consultations, individualized treatment planning, and ongoing support. When your care plan includes a prescription, fulfillment is coordinated through an independent licensed pharmacy.
Online, private, physician-guided. Most patients complete intake in minutes and receive their first plan within days.
Schedule your online consultation in under a minute. Pick the time that works for you.
Share your health history, goals, and symptoms through our secure, confidential portal.
Connect with a licensed provider via secure video to review labs and build your personalized plan.
If your matched independent licensed partner provider authorizes a prescription, an independent licensed pharmacy handles dispensing.
Health concerns don't always fit neatly into a single category. Hormones, metabolism, weight, and energy are deeply connected. Our telemedicine platform brings these services together in one place, making it easier to access thoughtful, physician-guided care from anywhere. We simplify care while maintaining the attention and oversight you expect from an in-person medical practice.
How medications and peptides work here: Each is commonly prescribed by our partner medical providers and shipped from the pharmacy to your home. Suitability, formulation, route, dosing, and monitoring are determined only by your matched licensed provider during consultation.
Membership Cadence
Monthly — $199/mo — pay month-to-month; cancel any month. Short-term trial or single-goal workup.
Quarterly — $499/qtr — $166.33/mo effective; saves $196 per year versus paying monthly for a year.
Annual — $1,899/yr — $158.25/mo effective; saves $489 per year versus paying monthly for a year (20.5% off). Lowest unit price.
Same membership pricing on every offering — care coordination only; medications handled separately by an independent licensed pharmacy.
Independent provider oversight, lab review, treatment adjustments and progress tracking — coordinated end to end.
Covers a comprehensive medical chart review, metabolic health triage, and independent clinical assessment for weight-management protocols.
Provides 90 days of continuous provider oversight, lab data monitoring, and metabolic treatment adjustments.
A full year of structured medical evaluation, long-term weight-management tracking, and ongoing clinical safety checks.
Agents most frequently cited in current U.S. compounding-pharmacy and telehealth formularies for metabolic and weight-management care. Each is referenced as a class, not as a brand recommendation or dosing choice.
GLP-1 receptor agonist that curbs appetite and slows digestion; supports sustained weight loss and improved glycemic control. Modalities: subcutaneous injection (weekly); oral tablet.
Dual GIP/GLP-1 receptor agonist that reduces appetite and improves insulin response. Modalities: subcutaneous injection (weekly); oral tablet.
GLP-1 agonist supporting appetite reduction and long-term weight management. Modalities: subcutaneous injection (daily).
Triple-agonist (GIP/GLP-1/glucagon) investigational peptide under study for weight loss and metabolic health. Modalities: subcutaneous injection (research-supply).
Generic oral biguanide that improves insulin sensitivity; widely used as a metabolic adjunct. Modalities: oral tablet.
Peptide hormone compounded off-label; referenced in metabolic-care literature. Modalities: intranasal spray; sublingual troche.
Sources: an independent U.S. tele-wellness compounding pharmacy Compounded Tirzepatide & Semaglutide guide (skippackpharmacy.com); FDA Drug Alerts on unapproved GLP-1 (fda.gov); currently published triple-agonist research literature.
Baseline evaluation, body-composition tracking, recovery protocols and ongoing clinical safety reviews — handled as one plan.
Covers the initial clinical screening, injury history review, and provider evaluation for tissue repair protocols.
A 3-month package covering physician oversight, body composition tracking, and clinical protocol adjustments.
Twelve months of routine medical evaluations, safety monitoring, and long-term cellular health tracking.
Peptides most frequently referenced in published research and in U.S. research-supplier catalogs for tissue repair, soft-tissue recovery, growth-hormone axis support and mitochondrial metabolism. All carry an explicit research-use or compounded-only status; none is FDA-approved for human clinical use outside of specific labeled indications.
Pentadecapeptide studied for soft-tissue repair, recovery acceleration, and gut-mucosa support. Modalities: subcutaneous injection; oral capsule; topical cream.
Thymosin β4 fragment analog studied for tissue regeneration and recovery support. Modalities: subcutaneous injection.
α-MSH tripeptide fragment studied for anti-inflammatory and mucosal support. Modalities: oral capsule; topical cream.
GHRH analog studied for growth-hormone-axis support and recovery. Modalities: subcutaneous injection.
Mitochondrial-derived peptide studied for cellular-energy and metabolic support. Modalities: subcutaneous injection; oral capsule.
Sources: currently published research guides and peer-reviewed catalogs; currently published reference material on tissue-repair peptides.
Baseline cognitive review, focus assessments, quarterly progress monitoring and clinical follow-ups — coordinated for you.
Covers the baseline clinical cognitive review, focus evaluation, and independent provider triage.
Includes 90 days of physician-led monitoring, treatment efficacy tracking, and mental wellness oversight.
Synthetic nootropic peptides most frequently referenced in U.S. compounding-pharmacy and clinician-education literature for focus, memory and stress-resilience research. Neither carries FDA approval for clinical cognitive use.
Synthetic heptapeptide derived from tuftsin; supports stress response, mood regulation, and cognitive resilience. Modalities: intranasal spray; subcutaneous injection.
Synthetic peptide analog of ACTH (4-10); supports cognitive function, focus, and neuro-protection. Modalities: intranasal spray.
Sources: currently available clinical references on nootropic peptides; currently available clinical reference guides.
Skin and hair assessment, staging, treatment design and routine chart updates — managed together by your matched provider.
Covers the initial expert skin assessment, hair-loss staging, and clinical protocol design by a provider.
A full year of scheduled clinical evaluations, treatment tracking, and routine medical chart updates.
Topical and injectable compounds most frequently listed in dermatology compounders' formularies and in research literature for collagen, elastin and hair-support studies. Status reflects the labelling of each preparation as published by the source.
Copper-binding tripeptide that supports collagen synthesis, skin firmness, and healthy aging. Modalities: topical cream; subcutaneous injection.
Retinoid compounds supporting cellular turnover, dermal remodeling, and healthy aging. Modalities: topical cream; oral capsule (low-dose).
Sources: currently available dermatology-compounding literature; currently available GHK-Cu compounding literature; currently available GHK-Cu compounding literature.
Symptom triage, hormone level tracking, quarterly monitoring and long-term management — coordinated under one matched provider.
Covers the onboarding medical review, symptom triage, and independent provider evaluation for hormone imbalances.
Provides 90 days of close clinical monitoring, follow-up evaluations, and hormone level tracking.
A full year of comprehensive provider oversight, routine health checks, and long-term hormone care management.
FDA-approved and compounded agents most frequently cited by U.S. 503A hormone-compounding pharmacies and telehealth hormone-replacement clinics for male and female endocrine care, where they are dispensed only on a valid prescription.
Primary androgen used in male and female hormone-replacement protocols. Modalities: subcutaneous injection; topical cream/gel; subcutaneous pellet.
Estrogen formulations for menopausal hormone-replacement and perimenopause care. Modalities: oral tablet; transdermal patch; topical cream; subcutaneous pellet; vaginal cream.
Bioidentical progestin for hormone-replacement cycle support. Modalities: oral capsule; topical cream; vaginal gel; subcutaneous pellet.
Aromatase inhibitor that suppresses peripheral estrogen synthesis. Modalities: oral tablet.
Selective estrogen-receptor modulator that supports endogenous testosterone. Modalities: oral capsule.
Luteinizing-hormone mimetic for testicular function, fertility workups and PCT support. Modalities: subcutaneous injection; sublingual troche.
Sources: currently available hormone-compounding literature; currently available TRT compounding literature; currently available TRT-compounding reference guides; currently available SERM reference literature.
Sensitive intake, clinical review, treatment tracking and follow-ups — coordinated privately with an independent partner clinician.
Covers the sensitive medical history intake, clinical symptom review, and independent provider triage.
Includes 3 months of continuous provider access, treatment tracking, and clinical follow-ups.
Agents most frequently referenced by U.S. sexual-health telehealth clinics and compounding pharmacies for libido, arousal and erectile function support, all dispensed only on valid prescription following a clinical review.
Melanocortin-receptor agonist for female hypoactive sexual desire and arousal. Modalities: subcutaneous injection.
PDE5 inhibitor supporting erectile function. Modalities: oral tablet; sublingual troche.
Long-acting PDE5 inhibitor for erectile function and daily wellness use. Modalities: oral tablet.
Compounded peptide hormone supporting intimate arousal and emotional connection. Modalities: intranasal spray.
Melanocortin-receptor agonist with tanning/skin-pigmentation effects; supports libido and arousal. Modalities: subcutaneous injection; intranasal spray.
Sources: currently available sexual-health optimization literature; currently published reference material on melanocortin-receptor agonists.
Initial screening, longevity-biomarker review, energy metric tracking and clinical chart updates — handled as one plan.
Covers the initial medical screening, longevity biomarker review, and expert clinical protocol design.
Provides 90 days of provider monitoring, energy metric tracking, and routine clinical chart reviews.
Mitochondrial-support, NAD-precursor and putative longevity peptides most frequently cited in U.S. longevity-compounding pharmacies, longevity-clinician references and research-supplier literature. Several are compounded, others are research-use only.
Nicotinamide adenine dinucleotide precursor supporting cellular energy and mitochondrial function. Modalities: subcutaneous injection; intravenous infusion; intranasal spray.
Direct precursor to NAD+ supporting cellular longevity and metabolic resilience. Modalities: oral capsule; sublingual tablet.
Tetrapeptide studied for telomerase support, circadian rhythm, and longevity signaling. Modalities: subcutaneous injection.
NNMT inhibitor studied for cellular-energy metabolism and longevity support. Modalities: oral capsule.
Sources: currently available longevity-compounding literature; currently available longevity-compounding catalogs; currently published cellular-energy research catalogs.
Perrenia Wellness coordinates care across 48 U.S. states through our online platform. Not currently available in Alabama or Mississippi. Coordination memberships do not include medication; if your matched independent licensed provider authorizes a prescription, dispensing is handled separately by an independent licensed pharmacy. Perrenia does not dispense, ship, fulfill, or take title to any medication.
This is a separate, independent research supplier for clinicians, laboratory researchers and readers who need reference-grade compounds for analytical or educational purposes only — not clinical care, and not for human consumption. Compounds sold on the linked site are research-use only, not medications, not FDA-evaluated, and not subject to sterile-manufacturing controls. Perrenia Wellness does not sell, ship, dispense, or evaluate any research-grade compound.
Connect with care coordination — we will match you with an independent licensed partner provider to explore your hormone, metabolic, longevity or weight-management goals. Concierge care coordination memberships are $199 per month, $499 per quarter, or $1,899 per year (annual saves ~20% versus monthly). Membership covers consultations, lab review and lifestyle supplements — not medications.
Or call us at (910) 239-3100
At Perrenia Wellness, you receive individualized medical care without the barriers of traditional in-office visits. Our licensed providers take time to understand your symptoms, review your history, and develop treatment plans tailored to your goals — with ongoing follow-up and careful monitoring.
Founded on the belief that accessible care should still feel personal and thorough, our practice combines modern telemedicine with attentive, relationship-centered medicine.
Have questions or ready to begin? Reach our care team today.
All treatment decisions are made independently by licensed healthcare providers following an appropriate medical evaluation. A consultation does not guarantee that a prescription will be issued.
Perrenia Wellness Care LLC does not prescribe, dispense, ship, fulfill, or take title to any medication. When a matched independent licensed provider authorizes a prescription, dispensing is handled separately by an independent licensed pharmacy, which is solely responsible for shipping, replacement, recall handling and adverse-event reporting. Perrenia does not own, operate, or control any pharmacy. Availability of any individual therapy depends on the patient’s medical needs, applicable federal and state requirements, the matched provider's prescribing authority, pharmacy availability, and the regulatory status of the specific medication or compounded preparation.
Some therapies commonly described or marketed as “peptides” are not FDA-approved drugs, and inclusion above should not be interpreted as representing FDA approval or availability for every patient or jurisdiction.
